Sunday, August 25, 2019

The dangerous cocktail of substandard drugs and poor regulatory oversight in India

The dangerous cocktail of substandard drugs and poor regulatory oversight in India WHO estimates that one in ten medical products in low-and-middle-income countries is substandard or falsified. This includes India

from Moneycontrol Business News https://ift.tt/2ZA6pch

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...